Gu CY - Search Results

1

Exploration on the construction of a bladder cancer prognostic model based on disulfidptosis-related lncRNAs and its clinical significance.

Hu XC, Yu QY, Ding HP, Xiao F, Gu CY. Hu XC, et al. Among authors: gu cy. Sci Rep. 2024 Nov 5;14(1):26751. doi: 10.1038/s41598-024-78481-5. Sci Rep. 2024. PMID: 39500988 Free PMC article.

2

Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer.

Xiao F, Zhang H, Ding H, An C, Gu C. Xiao F, et al. Medicine (Baltimore). 2023 Nov 10;102(45):e35918. doi: 10.1097/MD.0000000000035918. Medicine (Baltimore). 2023. PMID: 37960820 Free PMC article.

3

Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation.

An C, Zhang J, Chu H, Gu C, Xiao F, Zhu F, Lu R, Shi H, Zhang H, Yi X. An C, et al. Pathol Oncol Res. 2016 Oct;22(4):763-8. doi: 10.1007/s12253-016-0067-4. Epub 2016 Apr 28. Pathol Oncol Res. 2016. PMID: 27126186 Free article.

4

Acidic tumor microenvironment-activatable fluorescent diagnostic probe for the rapid identification and resection of human tumors via spraying.

Liu J, Xu Z, Meng C, Wusiman S, Xie X, Wang Y, Xiao F, Gu C, Chen J, Ling CC, Li P, Yuan Z, Ling Y. Liu J, et al. Biosens Bioelectron. 2023 Aug 15;234:115343. doi: 10.1016/j.bios.2023.115343. Epub 2023 May 2. Biosens Bioelectron. 2023. PMID: 37167656

5

PGK1 can affect the prognosis and development of bladder cancer.

Gao M, Zhu H, Xu H, Jin X, Zheng G, Zhu J, Gu C, Wang X. Gao M, et al. Cancer Med. 2024 Sep;13(18):e70242. doi: 10.1002/cam4.70242. Cancer Med. 2024. PMID: 39315723 Free PMC article.

6

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis.

Ju L, Sun Y, Xue H, Chen L, Gu C, Shao J, Lu R, Luo X, Wei J, Ma X, Bian Z. Ju L, et al. Sci Rep. 2020 Feb 21;10(1):3201. doi: 10.1038/s41598-020-60138-8. Sci Rep. 2020. PMID: 32081971 Free PMC article.

7

miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.

Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F. Chen L, et al. Tumour Biol. 2016 Feb;37(2):2497-507. doi: 10.1007/s13277-015-4071-1. Epub 2015 Sep 18. Tumour Biol. 2016. PMID: 26385772

8

Gadoxetic Acid-Enhanced MRI-Based Radiomic Models for Preoperative Risk Prediction and Prognostic Assessment of Proliferative HCC.

Yan Z, Liu Z, Zhu G, Lu M, Zhang J, Liu M, Jiang J, Gu C, Wu X, Zhang T, Zhang X. Yan Z, et al. Acad Radiol. 2024 Aug 23:S1076-6332(24)00473-2. doi: 10.1016/j.acra.2024.07.040. Online ahead of print. Acad Radiol. 2024. PMID: 39181825

9

GLIPR2: a potential biomarker and therapeutic target unveiled - Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.

Lin W, Zhang S, Gu C, Zhu H, Liu Y. Lin W, et al. Front Immunol. 2024 Feb 26;15:1280525. doi: 10.3389/fimmu.2024.1280525. eCollection 2024. Front Immunol. 2024. PMID: 38476239 Free PMC article.

10

Preoperative Gadoxetic Acid-Enhanced MRI Features for Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma: Creating Nomograms for Risk Assessment.

Qu Q, Liu Z, Lu M, Xu L, Zhang J, Liu M, Jiang J, Gu C, Ma Q, Huang A, Zhang X, Zhang T. Qu Q, et al. J Magn Reson Imaging. 2024 Sep;60(3):1094-1110. doi: 10.1002/jmri.29187. Epub 2023 Dec 20. J Magn Reson Imaging. 2024. PMID: 38116997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters